After A $100 Haircut, Is Catalent An Oversold Pharma Play?

Catalent Persimmon Vaxcyte small stocks SLB Biotech Stocks Q3 earnings reports McCormick worst performing mega-cap stocks in September 2022 best performing mega-cap stocks in September 2022

Bargain hunters swooped in on Catalent stock after it entered oversold territory. Catalent’s end-market demand appears to be deteriorating. The disappointing start to the year led management to backpedal on its outlook. The company still has valuable partnerships with leading drug makers and consumer health companies. Last fall, Catalent, Inc. (NYSE:CTLT) climbed to a record […]